Finance

Lists
Why is ARTV down २.४५%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
US$ ६.७७
-२.४५%
(-०.१७) 1D
US$ ६.७७
०.००% (०.००)
After hours
Closed: अक्टोबर १२, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
US$ ६.९२
High
US$ ६.९४
Low
US$ ६.७३
Mkt. cap
३३.१० करोड
Avg. vol.
४.५६ लाख
Volume
२.४९ लाख
52-wk high
US$ १४.५३
52-wk low
US$ २.७१
EPS
-US$ ३.३१
Shares outstanding
४.८९ करोड
No. of employees
११५
Open
US$ ६.९२
High
US$ ६.९४
Low
US$ ६.७३
Mkt. cap
३३.१० करोड
Avg. vol.
४.५६ लाख
Volume
२.४९ लाख
52-wk high
US$ १४.५३
52-wk low
US$ २.७१
EPS
-US$ ३.३१
Shares outstanding
४.८९ करोड
No. of employees
११५
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees११५
Founded२०१९
Headquarters-
Sector-
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current US$ ६.७७
US$ ४१.०० (+५०५.६१%)
Average
US$ ३८.०० (+४६१.३०%)
Lowest
US$ ३५.०० (+४१६.९९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
US$ ४१.००
+५०५.६%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$ ३५.००
+४१७%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
US$ ४०.००
+४९०.८%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ २३.००
+२३९.७%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
US$ ४०.००
+४९०.८%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
US$ ४०.००
+४९०.८%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.७६ करोड
१.७० करोड
१.९३ करोड
२.१९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५२.६४ लाख
४९.३८ लाख
५१.१८ लाख
४९.६५ लाख
Operating expense
२.२९ करोड
२.१९ करोड
२.४४ करोड
२.६९ करोड
Total operating expenses
२.२९ करोड
२.१९ करोड
२.४४ करोड
२.६९ करोड
Operating income
-२.२९ करोड
-२.१९ करोड
-२.४४ करोड
-२.६९ करोड
Other non operating income
-३.०० हजार
-१८.८२ लाख
२.०० हजार
-१.०० हजार
EBT including unusual items
-२.१५ करोड
-२.०८ करोड
-२.३५ करोड
-२.५० करोड
EBT excluding unusual items
-२.१५ करोड
-२.२७ करोड
-२.३५ करोड
-२.५० करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.१५ करोड
-२.०८ करोड
-२.३५ करोड
-२.५० करोड
Net profit margin
-
-
-
-
Earnings per share
-०.८८
-०.८४
-०.९५
-०.६३
Interest and investment income
१३.७२ लाख
११.६२ लाख
९.१२ लाख
१८.८६ लाख
Interest expense
-
-
-
-
Net interest expenses
१३.७२ लाख
११.६२ लाख
९.१२ लाख
१८.८६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.२२ करोड
-२.१३ करोड
-२.३८ करोड
-२.६२ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू